WASHINGTON, April 18 (Reuters) - U.S. President Donald Trump signed an executive order on Saturday intended to speed up access to medical research and treatment based on psychedelic ‌drugs. The order ...
By Kamal Choudhury and Christy Santhosh May 18 (Reuters) - U.S. President Donald Trump's executive order to accelerate psychedelic drug development has raised hopes among companies developing the ...
The White House is in for a trip.
President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs." "The ...
Catholic Mental Health Professionals React to Executive Order Removing Barriers to Psychedelic Drugs
The executive order notes that more than 14 million American adults now suffer from serious mental illness, a large rise from a decade ago. Trump’s executive order instructs the Food and Drug ...
After taping Joe Rogan’s podcast in late March, former Texas governor Rick Perry (R) and ibogaine advocate W. Bryan Hubbard made an unusual request: “Mr. Rogan, would you be willing to consider asking ...
President Trump recently signed an order to speed up the evaluation of psychedelics to treat the brain. That's coming after decades of strict prohibition on psychedelic drug use dating back to ...
FILE PHOTO: U.S. President Donald Trump signs an executive order encouraging more research into ibogaine, next to U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., Joe Rogan, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results